| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9832 |
| Human Intestinal Absorption | HIA+ | 0.9899 |
| Caco-2 Permeability | Caco2+ | 0.7813 |
| P-glycoprotein Substrate | Non-substrate | 0.8698 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9775 |
| Non-inhibitor | 0.9836 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9205 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4860 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8392 |
| CYP450 2D6 Substrate | Non-substrate | 0.9246 |
| CYP450 3A4 Substrate | Non-substrate | 0.8277 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8455 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9711 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9766 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9711 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9890 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9361 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9573 |
| Non-inhibitor | 0.9825 |
| AMES Toxicity | Non AMES toxic | 0.5399 |
| Carcinogens | Carcinogens | 0.6529 |
| Fish Toxicity | Low FHMT | 0.6241 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8681 |
| Honey Bee Toxicity | High HBT | 0.8111 |
| Biodegradation | Ready biodegradable | 0.8236 |
| Acute Oral Toxicity | III | 0.4919 |
| Carcinogenicity (Three-class) | Non-required | 0.6819 |